Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

BMY 72.18 -0.08 (-0.11%)
price chart
Stock to Watch for Earnings: Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) on April 28, 2016 reported results for the first quarter of 2016, which were highlighted by strong sales for Opdivo, Eliquis and hepatitis C franchise along with significant regulatory milestones and key data in ...
BRISTOL-MYERS SQUIBB CO (BMY) Earnings Report: Q1 2016 Conference Call ...  TheStreet.com
Bristol-Myers Squibb Co. | $BMY Stock | Shares Gap Up On Solid First Quarter ...  TickerTV News (press release)
Stock's Overbuying Recap: Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) has an ABR 2.37 which is the combined stock view of 15 analysts poll results. As per the Zacks simplified descending rating scale, the ABR rank is displayed in the range of 1 to 5 where 1 represents a Strong Buy and 5 ...
Share Performance and Target Price Review Bristol-Myers Squibb Company (NYSE ...  B.O.D.Y Confidential
Notable Analysts Recommendation to Monitor: Bristol-Myers Squibb Company (NYSE ...
Bristol-Myers Squibb Company (NYSE:BMY) increased +2.89% or +2.03 points. The company traded volume of 13.73 million shares more than average volume of 6.51 million shares.
Bristol-Myers Squibb Company (BMY) Falls Further As It's Water-Logged And ...
Trade-Ideas LLC identified Bristol-Myers Squibb Company ( BMY) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate.
Bristol-Myers Squibb Co Q1 Earnings: Here's What to Expect  Bidness ETC
Bristol-Myers Squibb to Take Part in Deutsche Bank Annual Health Care Conference  Business Wire (press release)
Bristol-Myers Squibb Co (BMY): How it Took an Unbeatable Lead in Immuno ...
Bristol-Myers Squibb Co (NYSE:BMY) presented clinical data at the annual meeting of American Association for Cancer Research (AACR) mentioning that Opdivo (nivolumab) can enhance the survival rate in patients suffering from recurrent or metastatic ...
Bristol-Myers Squibb Company (BMY) Analyst Estimates  Zergwatch
Stock to Buy: Many Are Considering Bristol-Myers Squibb Co (NYSE:BMY)  The Point Review
Analysts Reviewing Stocks: OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI ...
Bristol-Myers Squibb Company (NYSE:BMY) showed bullish move with gain of +0.33% after exchanging volume of 4.6 million shares in last trading session ended on 4/26/2016.
HC Stocks in Drift: Medtronic PLC (MDT), Bristol-Myers Squibb Co (BMY), Merck ...
Shares of Medtronic PLC (NYSE:MDT) ended Wednesday session in green amid volatile trading. The shares closed up +0.73 points or 0.93% at $79.45 with 7.86 million shares getting traded.
Overbuying Stock in the Spotlight: Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) has an ABR 2.37 which is the combined stock view of 15 analysts poll results. As per the Zacks simplified descending rating scale, the ABR rank is displayed in the range of 1 to 5 where 1 represents a Strong Buy and 5 ...
Check-up on Energy: XOM and CVX Earnings Preview
Lots of FDA-approval news on Bristol-Myers Squibb Company (NYSE: BMY) products in recent sessions has helped propel the stock but won't likely be represented in the Q1 earnings when the pharma giant reports ahead of the market's open on Thursday.
Bristol-Myers Squibb Company (NYSE:BMY) Consensus Recommendation Update
Zacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 13 equity research firms that cover shares of Bristol-Myers Squibb Company ...